Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA advisory on AIDS drugs

June 17, 1997

3-Dimensional Pharmaceuticals licenses thrombin inhibitors to Wyeth-Ayerst

June 17, 1997

Centocor's tumor marker assay now available for use in the U.S.

June 17, 1997

Interferon/ribavirin compared to interferon and ribavirin monotherapy in chronic hepatitis C

June 17, 1997

Neuroprotective effects of ZD-9379 in rat model

June 17, 1997

Cypros technology for prevention of organ transplant rejection covered under U.S. patent

June 17, 1997

Proischemic effect of enalapril in MI

June 17, 1997

New asthma treatment now available in Canada

June 17, 1997

Zonagen reports results of second phase III trial of Vasomax

June 17, 1997

Milkhaus receives FDA approval to start phase II cystic fibrosis trial

June 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...